The cost of tetanus treatment is influenced by multiple clinical and systemic factors. Severe infections requiring intensive care, mechanical ventilation, and prolonged hospitalization significantly increase expenses compared to milder cases. Additional costs arise from essential interventions such as tetanus immune globulin administration, antibiotic therapy, wound management, and supportive care. Furthermore, regional variations in healthcare infrastructure, resource availability, and labor costs contribute to differences in overall treatment expenditure, underscoring the importance of context-specific healthcare planning and resource allocation.